Onderneming Medicenna Therapeutics Corp.
Aandelen
MDNA
CA58490H1073
Biotechnologie & Medisch Onderzoek
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
2,85 CAD | +22,84% | +20,76% | +578,57% |
Vakgebied
Aantal werknemers: 16
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Founder | - | 01-10-11 | |
Fahar Merchant
CEO | Chief Executive Officer | - | 02-02-15 |
David Hyman
DFI | Director of Finance/CFO | - | 14/02 |
Delphine Davan
IRC | Investor Relations Contact | - | 14-08-23 |
Minh To
PRN | Corporate Officer/Principal | - | 14-08-23 |
Eamonn Peters
PRN | Corporate Officer/Principal | - | 14-08-23 |
Evelyn Pau
PRN | Corporate Officer/Principal | - | 14-08-23 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Karen Dawes
BRD | Director/Board Member | 72 | 24-09-19 |
Albert Beraldo
BRD | Director/Board Member | - | 22-11-16 |
Fahar Merchant
CEO | Chief Executive Officer | - | 02-02-15 |
Founder | - | 01-10-11 | |
Jack Geltosky
BRD | Director/Board Member | 78 | 30-09-20 |
John Sampson
BRD | Director/Board Member | - | 23-09-21 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 74 778 857 | 53 700 082 ( 71,81 %) | 0 | 71,81 % |
Bedrijfsgegevens
Sector
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+578,57% | 156 mln. | |
+43,36% | 54,63 mld. | |
-5,31% | 39,92 mld. | |
+14,75% | 26,86 mld. | |
-12,56% | 26,22 mld. | |
-22,45% | 18,78 mld. | |
+25,12% | 12,21 mld. | |
+0,04% | 12,16 mld. | |
+26,04% | 11,94 mld. | |
-11,83% | 10,74 mld. |
- Beurs
- Aandelen
- Koers MDNA
- Onderneming Medicenna Therapeutics Corp.